Skip to content
Scottsdale Biologics Register
Reading the label on joint injections

Scottsdale Biologics Register

Biologic therapy in Scottsdale means blood-based shots at a local clinic

Save the address before you leave. The Scottsdale office is nearby for many residents, but the drive is longer from the far north.

Bring your X-ray and medicine list. They can make the first visit more useful.

The Scottsdale clinic is near Shea Boulevard

The Scottsdale QC Kinetix office sits in the 85258 zip. It is near Shea Boulevard, just east of Loop 101.

This location is closest for most Scottsdale residents. You won't need to cross the whole Valley.

The clinic referral gives the exact street address and phone number. Save both before you start driving.

Far north Scottsdale has a longer drive

McCormick Ranch has the shortest trip. Gainey Ranch and Scottsdale Ranch are also close.

The Waterfront and Old Town sit farther south. Airpark and Kierland residents come down toward Shea Boulevard.

Allow more time from Desert Mountain, Terravita, Pinnacle Peak, or Troon North. Those homes sit far north of the clinic.

The Chandler office on South Dobson Road may suit the far south end. The Scottsdale office is closer for most others.

The consultation explains the shot and its cost

The Scottsdale QC Kinetix office offers regenerative treatments, meaning shots prepared there from your blood. The first consultation has no charge.

For PRP, a machine saves platelets, tiny blood pieces used in clotting and healing. They'll place those pieces in your joint with a shot.

You'll hear whether that choice fits and what the full care costs. You don't have to book treatment.

Bring what the provider needs for the exam

A medical provider is the licensed clinic worker who checks your joint. Bring any recent X-ray and a medicine list.

Note when the trouble began and the tasks that bring it on. Wear clothes that let the provider reach the joint.

Bring questions about recovery, activity, and payment. You'll leave knowing what comes next.

Sources

  1. Medicare's national coverage determination states that CMS covers autologous platelet-rich plasma ONLY for patients with chronic non-healing diabetic, pressure and/or venous wounds, and only inside an approved coverage-with-evidence-development clinical study. Every approved study listed under the NCD is a wound-healing study. There is no Medicare national coverage for PRP in osteoarthritis or tendinopathy, which is why these injections are billed to the patient.

    Centers for Medicare & Medicaid Services — Autologous Platelet-rich Plasma (Coverage with Evidence Development). CMS.gov, 2024.

  2. FDA's patient and consumer notice on regenerative medicine states that it has received reports of BLINDNESS, TUMOUR FORMATION, neurological events, bacterial infections including life-threatening blood infections, unwanted immune reactions, and cells migrating and forming unintended tissue, following the use of unapproved regenerative medicine products - a list that explicitly includes stromal vascular fraction, amniotic fluid, Wharton's jelly, ortho-biologics and exosomes. It also warns that a product's presence on clinicaltrials.gov, or a firm's registration with FDA, does NOT mean the product is legally marketed.

    U.S. Food and Drug Administration — Important Patient and Consumer Information About Regenerative Medicine Therapies. FDA (Center for Biologics Evaluation and Research), 2021.

  3. FDA's July 2020 final guidance 'Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use' is the document that decides whether a given orthobiologic can be used without a licence: an HCT/P may be regulated solely under section 361 only if it is minimally manipulated AND intended for homologous use, among other criteria; otherwise it is a drug or biological product requiring an approved licence or an active investigational new drug application.

    U.S. Food and Drug Administration — Regulatory Considerations for Human Cells, Tissues, and Cellular and Tissue-Based Products: Minimal Manipulation and Homologous Use - Guidance for Industry and Food and Drug Administration Staff. FDA Guidance Document, 2020.

An exam can give you a clear next step

Home care has limits. A medical provider checks your joint and explains the likely cause.

After that exam, QC Kinetix may offer non-surgical care. You'll hear the cost, time, and effort before deciding.

You can ask questions and leave without booking treatment. That's still a useful visit.

Book a free consultation